NL-OMON28106暂停不适用
A phase II study of ARA 290 as therapeutic strategy in no-option critical limb ischemia patients.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- MC
- 入组人数
- 12
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Critical limb ischemia;
- •2. No option for conventional revascularization;
排除标准
- •1. Poorly regulated diabetic disease (HbA1c >10%);
- •2. Clinically relevant abnormal history of physical and mental health other than conditions related to CLI, as determined by medical history taking (as judged by the investigator);
研究者
相似试验
撤回
2 期
A phase II study of ARA 290 as therapeutic strategy in no-option critical limb ischemia patients.Critical limb ischemia1004079510003216NL-OMON34878eids Universitair Medisch Centrum12
进行中（未招募）
不适用
A phase II study of ARA 290 as therapeutic strategy in rheumatoid arthritis - ARA 290 in ARAMedDRA version: 12.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisMedDRA version: 12.1Level: PTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2010-023469-22-NLMC12
已完成
2 期
A phase II study of ARA 290 as therapeutic strategy in rheumatoid arthritis1000381610023213rheumatoid arthritisNL-OMON36765eids Universitair Medisch Centrum14
进行中（未招募）
不适用
A phase II study of ARA290 as therapeutic strategy in no-option critical limb ischemia patients.Critical Limb IschemiaMedDRA version: 12.1Level: LLTClassification code 10058069Term: Critical limb ischemiaEUCTR2010-018584-41-NLMC8
已完成
2 期
Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With SarcoidosisNeuropathy of SarcoidosisNCT02039687Araim Pharmaceuticals, Inc.64